Euractiv’s Advocacy Lab is responsible for the production of all Euractiv content supported by a third party. With its own team of reporters and a managing editor, Euractiv’s Advocacy Lab offers in-depth coverage of stakeholder perspectives.
New metal production practices prompted by revised expectations from governments and investors are already affecting countries like Indonesia. However, there are concerns about rising costs and a lack of regulatory coordination.
Russia's invasion of Ukraine has prompted most European member states to consider significantly boosting military spending after years of underinvestment. Many national budgets have already increased military expenditures. What next for the defence industry base?
Kazakhstan is a growing market opportunity for European agricultural food and beverage exports, says Wojciechowski, underlining what he hails as the emerging importance of an evolving EU-Kazakh relationship.
Scalability for Europe’s innovators requires private capital - climate change and digitalisation demand that capital quickly. Europe needs more and better investment in key sectors to drive Europe’s place in the world, says Invest Europe.
The Swedish Medical Products Agency is seeking a new mandate to address drug shortages. It wants to take charge of redistributing critical medicines to pharmacies and setting up a stock-based situational awareness system.
Hospitals in Hungary are sounding alarm as rising debts restrict operations, with officials reporting there are very few medical interventions for which the available funding provides sufficient financial coverage.
The Polish government has reallocated €139.5 million from the National Recovery Plan to support the zero-emission economy. The move upset the Polish pharmaceutical sector as the funds were originally intended for drug production.
Belgium's political landscape is undergoing a reshuffle, raising critical questions about how the new Belgian government will address the fragmented state of healthcare. Re-federalisation of the healthcare system is an idea gaining traction.
Czechia has enforced new legislation since 1 June aimed at reducing the impact of drug shortages on patients while enhancing the efficiency of the pharmaceutical market.
Whooping cough incidence in Sweden is on the rise. The Swedish chief epidemiologist advises parents to keep their babies away from people with cold symptoms - similar trends are now seen in other parts of Europe.
Lithium is a key component in the manufacturing of batteries for electric cars and was recently added to the EU’s list of critical raw materials considered essential for the manufacturing of electric car batteries, mobile phones, and laptop computers.
In this first discussion, supported by ACE, we delved into the Packaging and Packaging Waste Regulation (PPWR).
The future of Belgium’s pharmaceutical industry is under scrutiny as competition challenges Belgian success. Leading Belgian politicians discussed revamping pharma's road map in a recent conversation with Euractiv.
As Slovak voters go to the polls candidates are fighting for Slovakia's 15 MEP seats with substantially different visions of how EU health legislation should be directed - the EU Pharma Package is central to current concerns.
In conversation with Euractiv’s Anna Gumbau, Andreas Schwab and Jens Bresler explain the leadership challenges and opportunities in light of the latest EU policies for a sustainable transition.
Natural disasters prompted by climate change are putting pressure on EU forest resilience, but the bloc’s Forest Monitoring Law could help forest owners, researchers, policymakers and civil society address these risks.
In the face of escalating ecological, social, economic, and political challenges threatening life on Earth, a European network championing community-led climate change and sustainability initiatives has evolved.
Beijing has toughened its critical tone towards the European Union’s protectionist measures against China, warning of increased friction in trade relations. As a trade war brews, the EU is uniting with Japan in fending off Chinese clean tech competition.
To catch the enlargement train, EU candidate countries must run simultaneously with the European Union, argues the EESC’s Dimitris Dimitriadis. He says responsibility for an increasing Western Balkans' disillusionment with the EU is shared.
Cardiovascular disease related to diabetes is wrecking Europe’s public health budgets at an astonishing rate. Patients with diabetes are three times more likely to develop CVD, while one in three will experience some form of vision loss.
Investors champion biotechnology with AI as the engine of the Fourth Industrial Revolution, but despite Europe’s strong ambitions biotech analysts say legislation designed for chemicals is not fit for the biological. The result is an exodus of talent and investment.
Regional revitalization – driven by green policies and technological advancements – is a key priority across Europe, and it is clear that this transformation is most urgent in rural, post- industrial, and suburban areas adjacent to major cities.
It is estimated that over 7 million people are living with Alzheimer's Disease in Europe, and there is increasing concern about the ability to combat the disease with Europe's ageing population. In this series of articles, Euractiv will explore the state …
